We found that Ku70, a known DNA repair factor, has a novel function to bind and inhibit Bax (Bcl-2-associated X protein), a key mediator of apoptosis. Pentapeptides derived from the Bax-binding domain of Ku70 were cell-permeable and protected cells from Bax-mediated apoptosis. These pentapeptides were called BIPs (Bax-inhibiting peptides). BIPs may become a useful therapeutic tool to reduce cellular damage. We also generated BIP mutant pentapeptides that do not inhibit Bax, but retain their cell-penetrating activity. Since both BIPs and BIP mutants are cell-permeable, these peptides were designated CPP5s (cell-penetrating pentapeptides). Among the CPP5s discovered, VPTLK (BIP) and KLPVM (BIP mutant) were confirmed to possess protein transduction activity by examination of the delivery of GFP (green fluorescent protein) into cells by these peptides. The mechanism of cell penetration by CPP5s is not known. CPP5s enter the cell at 0 and 4
BIP (Bax-inhibiting peptide) derived from Ku70
Ku70 was identified as a Bax (Bcl-2-associated X protein) suppressor by use of a yeast-based functional screen Bax, a 21 kDa protein, is a member of the Bcl-2 family of proteins, which plays a key role in programmed cell death [1, 2] . Bax normally resides in the cytosol and translocates into mitochondria on onset of apoptotic stresses [3] . This observation suggests that there are Bax-inhibiting proteins in the cytosol, and the activities of these Bax inhibitors can be diminished by the presence of apoptotic stress. In order to identify potential Bax inhibitors, we developed a yeast-based functional screening system [4, 5] . Ectopic expression of Bax in budding yeast confers a cell death phenotype [4, 5] . Taking advantage of this phenotype, we screened a human cDNA library to identify genes that rescued yeast from Bax-induced cell death. As a result, Ku70, a 70 kDa (609 amino acids)
Key words: Bax-inhibiting peptide (BIP), cell-penetrating peptide (CPP), drug delivery, pentapeptide. Abbreviations used: Bax, Bcl-2-associated X protein; BIP, Bax-inhibiting peptide; CPP(5), cell-penetrating (penta)peptide; EGF, epidermal growth factor; Fam, fluorescein; GFP, green fluorescent protein; HEK-293 cell, human embryonic kidney cell; HUVEC, human umbilicalvein endothelial cell; NHEJ, non-homologous end-joining; Tat(p), transactivator of transcription (peptide). 1 To whom correspondence should be addressed (email shigemi.matsuyama@case.edu).
subunit of the Ku protein complex, was identified as a new Bax inhibitor (reviewed in [6] ). The Ku complex consists of Ku70 and Ku80 (86 kDa subunit), and Ku is required for double-stranded DNA break-repair by the NHEJ (nonhomologous end-joining) pathway. Ku70 is resident in the nucleus, cytosol and plasma membrane [7, 8] .
We found that the cytosolic form of Ku70 binds and inhibits Bax (Figure 1) . Importantly, the Bax-binding domain of Ku70 was identified to be the region of amino acids 578-583, and pentapeptides derived from this domain were sufficient to bind and inhibit Bax (Figure 1 ) [6, 9] . These Ku70-derived pentapeptides do not function in the NHEJ pathway, since these peptides cannot form a functional Ku complex with Ku80. These findings suggest that cytosolic Ku70 has a cytoprotective role as a Bax inhibitor, independently of its DNA repair activity in the nucleus. These observations have been confirmed and reproduced by several groups [10] [11] [12] [13] [14] [15] . It has been confirmed that Ku70 inhibited apoptosis in Ku80-deficient cells [11, 14] , supporting our hypothesis that the anti-Bax activity of Ku70 is independent of the NHEJ pathway. Cohen et al. [11, 12] reported that acetylation of Ku70 dissociates Ku70 from Bax, and thus Ku70 acetylation promotes apoptosis, whereas Ku70 deacetylation attenuates apoptosis of stressed cells. We found that apoptotic stresses stimulated Ku70 ubiquitination, which facilitated proteasome-dependent proteolysis of Ku70 [16] . This observation suggests that Ku70 degradation is one of the steps necessary to activate Bax. We suggest that the Ku70-ubiquitin-conjugating enzyme activates Bax through mediation of cell stress. The search for a Ku70 ubiquitinating enzyme is currently underway.
In our preliminary study, we found that the approximate concentrations of Ku70 and Bax in human cells were 40 and 0.8 µM respectively (J.A. Gomez, V. Gama and S. Matsuyama, unpublished work). HUVECs (human umbilical-vein endothelial cells), HEK-293 cells (human embryonic kidney cells) and Dami cells (human megakaryocyte-like cell line) were examined, and the concentrations of Ku70 and Bax were estimated by measuring Ku70 and Bax levels in wholecell lysates by Western blotting using purified recombinant Ku70 and Bax proteins for comparison. Our preliminary data showed that the concentration of Ku80 in human cells is approx. 2 µM, which is less than that of Ku70 (40 µM estimated concentration in human cells) (J.A. Gomez, V. Gama and S. Matsuyama, unpublished work). This stoichiometry suggested that the majority of Ku70 molecules are not bound to Ku80, and that these monomeric Ku70 proteins may be required for anti-Bax activity, as well as multiple varied cellular functions that are not related to NHEJ activity [8, 17] .
BIPs
Our results showed that pentapeptides derived from the Bax-binding domain of Ku70 were cell-permeable and they protected cells from Bax-mediated cell death (Figures 2 and 3) [6, 9] . These peptides were designated as BIPs (Baxinhibiting peptides) [6, 9] , and BIPs derived from Ku70 of various species showed similar cell permeability and cell death inhibition [6, 9] . Cell-penetrating activity was confirmed by the detection of Fam (fluorescein)-labelled BIP by microscopy and FACS analysis ( Figure 2 ). Fam-BIP was detected in the cytosol when cells were incubated with 10 µM Fam-BIP. BIPs did not show significant toxicity, even when BIP peptides were added to the culture medium at 1.6 mM, owing to the role of BIPs in inhibition of cell death [6] . In order for effective suppression of cell death (induced either by cellular stress or by drug treatment), 50-400 µM BIPs in the culture medium showed effective suppression, but this was dependent on the cell type examined and the apoptotic stresses induced [6, 9, 10, 18, 19] . As described previously, the concentration of Ku70 in the cell is approx. 40 µM. In order to maintain the inactive status of Bax by BIPs in damaged cells, the concentration of BIPs in these damaged cells may have to be at a higher concentration, or a similar concentration to that of Ku70 in non-apoptotic cells. This may be the reason that more than 50 µM of BIP in the culture medium is necessary in order to inhibit cell death. The cytoprotective activity of BIPs has been shown in animal models by other groups [20, 21] . For example, BIPs protected retinal ganglion cells from apoptosis triggered by optic nerve injury [20] . BIPs also increased the efficacy of liver cell transplantation in the mouse [21] .
CPP5s (cell-penetrating pentapeptides)
CPPs (cell-penetrating peptides)
CPPs are a group of newly designed peptides that are able to translocate through the plasma membrane or use pinocytic pathways to enter mammalian cells [22] [23] [24] [25] [26] . Previously identified CPPs showed protein transduction activity through transportation of cargo proteins into mammalian cells [22] [23] [24] [25] [26] . The list of CPPs has increased since the first report of cell penetration by the Antennapedia homeobox peptide from Drosophila, which was later recognized to be a CPP [27] . The first report of a complete protein penetrating into mammalian cells was the HIV-Tat (transactivator of transcription) protein [28, 29] , from which the cell-permeable Tatp (Tat peptide) was derived [30] [31] [32] . There are also synthetic peptides which are able to enter mammalian cells [22] . Among the synthetic peptides, the arginine-rich peptide derived from Tatp [26, 33, 34] , amphipathic peptides [22, 35] and transportan [22, 36, 37] are representatives of this class.
CPP5s
As described earlier, BIPs are CPP5s, and BIPs are categorized as the shortest CPPs [38] . To confirm that BIPs protect cells by binding and inhibiting Bax, we generated a series of mutated forms of BIPs that do not bind Bax, but retain the cell-penetrating activity (Figure 3 ). In fact, these mutant BIPs did not show any significant cytoprotective activity. The mutated BIPs were used as negative-control peptides in order to study the mechanism of Ku70-dependent Bax inhibition (Figure 3b) [6, 9, 10] . Importantly, both BIPs and the BIP mutants are cell-permeable and can be categorized as CPP5s, regardless of Bax-inhibiting activity. We found that CPP5s are capable of delivering cargo proteins across the plasma membrane, at least in cell culture.
The amino acid sequence of CPP5s
As shown in Figure 3 , CPP5s have a common chemical character, consisting of one or two charged polar amino acids at either the N-or C-terminus, and also three to four non-polar amino acids. This structure creates bipolar activity of CPP5s. Interestingly, both positively charged (lysine and arginine) and negatively charged (glutamic acid) amino acids confer on BIPs the capacity to penetrate the plasma membrane. In the case of HIV-Tat and poly-arginine peptides, the positive charge is critical for the cell-penetrating activity. Therefore CPP5s seem to enter the cell through a mechanism distinct from that employed by the HIV-Tat and poly-arginine peptides. We speculate that the amphipathic sequence of CPP5s allows association of the peptides with the hydrophilic cell surface, through the charged amino acids, and penetrates the hydrophobic lipid layer using the non-polar amino acids present on the peptide. Currently, there has been no definitive answer as to whether a specific receptor/receptors exist for CPP5s. Further investigation of potential CPP5 receptors is needed for the elucidation of the mechanism of cell penetration and protein transduction by CPP5s.
CPP5s in the cell
We have confirmed that CPP5s can enter HUVECs, primary cultured mouse megakaryocytes, HEK-293 cells, Dami cells and HeLa cells. In addition, there are several reports by other groups indicating that BIPs showed cell-penetrating activity in other cell types [6, 9, 10, [18] [19] [20] [21] . Figure 2 shows nonfixed HeLa cells incubated with Flu-labelled KLPVM and VPTLK peptides. Confocal microscopy showed that CPP5s localized mainly to the cytosol in the majority of the cell types examined, although CPP5s could be detected almost equally in the cytosol and nucleus in certain cell lines, such as Du145 (human prostate cancer cell line). Since BIPs interact with Bax, the complex formation with Bax in the cytosol is one of the theoretical factors in the accumulation of BIPs in the cytosol. However, BIP mutants also showed cytosolic localization, and the concentration of Bax in the cytosol (approx. 0.8 µM in non-apoptotic human cells) is much less than the concentration of BIPs in the medium (approx. 50-400 µM). Therefore we speculate that there are CPP5-binding factors present in the cytosol other than Bax.
Interestingly, the cell-penetrating activity of CPP5s varies depending on the cell type. For example, Flu-CPP5s can be detected in the cytosol within 15 min of addition of peptides into the medium, in the case of HeLa cells, HEK-293 cells and Dami cells [6] . However, more than 12 h of incubation was required to detect Fam-CPP5 in the cytosol, in the case of primary cultured mouse megakaryocytes (J. Gomez and S. Matsuyama, unpublished work). Primary cultured mouse cortical neuronal cells also showed slow uptake of CPP5s (J. Gomez and S. Matsuyama, unpublished work). This variation may be due to the different activities of endocytic and pinocytic pathways, as well as differences in the expression levels of currently unidentified CPP5 receptors. The difference in lipid composition among cell types may also be a factor influencing the cell-penetrating activity of CPP5s.
Mechanism of cell penetration by CPP5s
The CPP5s, KLPVM, VPTLK, IPMIK, VPMLK and VPALR, were examined and showed cell-penetrating activity, even at 0 and 4
• C [6] . This observation suggests their ability to translocate through the plasma membrane using a non-energy-dependent mechanism, such as endocytosis. However, the cell-penetrating activity at 4
• C was approx. 25% of the activity at 37
• C (measured by FACS of FamCPP5s in the cell) [6] . These results suggest that an energydependent mechanism also plays an important role in the cell penetration of CPP5 under physiological conditions.
To study further the mechanism of cell penetration by two CPP5s, KLPVM and VPTLK, various inhibitors of pinocytosis were tested. HeLa cells were incubated for 30 min in the absence or presence of various inhibitors: amiloride (5 mM), chlorpromazine (28 µM), cytochalasin D (10 µM), nocodazole (2 µM) and methyl-β-cyclodextrin (20 µM), followed by addition of Fam-labelled CPP5s (100 µM), and incubation for 1 h with Fam-labelled poly-arginine peptide, R 8 (10 µM). Fam-labelled Tatp (YGRKKRRQRRR, 10 µM), FITC-conjugated transferrin (1.4 µM) and Rhodaminelabelled EGF (epidermal growth factor) (15 nM) were used as positive controls. Interestingly, none of the inhibitors tested blocked the entry of CPP5s into cells, although the cellpenetrating activity of Tatp and EGF were inhibited by at least one of the inhibitors. These results suggested that CPP5s use a currently unidentified mechanism in order to enter the cell. However, the concentration of 100 µM Fam-labelled CPP5s may be too high to examine the effects of the cellular inhibitors. Currently, investigation of lower concentrations of CPP5s is ongoing to examine further whether these inhibitors show any significant inhibition on the cellular entry of CPP5s.
Delivery of GFP (green fluorescent protein) by CPP5
We examined whether CPP5s have cargo-delivery activity using a GFP-tagged CPP5 fusion protein. Two CPP5s, VPTLK and KLPVM, were fused on to the C-terminus of GFPuv (TaKaRa Co.), with EcoRI and SacI sites used for CPP5 fusion. Purified recombinant GFP-CPP5s were added to the culture medium of HeLa cells at concentrations of between 20 and 1000 nM. GFP-CPP5s were detected in the cytosol by confocal microscopy, whereas control GFP was not detected (Figure 2 ). These results suggest that CPP5s have protein transduction abililty. A further detailed study is currently underway into the potential of CPP5s in cargo delivery.
Future application of CPP5s
The unique character of CPP5s is their very low toxicity in cells. BIPs are fundamentally cytoprotective peptides and so did not demonstrate significant cytotoxicity, even at a concentration of 1.6 mM in the culture medium when tested in Dami cells [6] . BIP mutants also showed very low toxicity, and significant cytotoxicity was not detected in Dami cells, even at a concentration of 1 mM in the culture medium. Furthermore, we examined the toxicity of VPTLK (a CPP5) in mice by use of 166.5 mg/kg VPTLK (approx. 300 µM dose throughout the mouse) by i.p. (intraperitoneal) injection and 16.5 mg/kg VPTLK by i.v. (intravenous) delivery. Mice treated with BIPs at these doses did not show any sign of illness and lived more than 3 months after treatment. Since CPP5s have very low toxicity, they may be useful to deliver cargo molecules to damaged cells, in order to restore their function. In addition, CPP5s may be useful in bio-imaging technologies, in order to mark target cells in vivo. The development of new technologies using CPP5s is now ongoing.
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